Posted on: 24 June, 2025
A fascinating and informative podcast has been launched showcasing groundbreaking research, innovative healthcare, and inspiring stories from across Northern Sydney.
Tomorrow’s Medicine Today is an initiative of the Northern Sydney Local Health District and the Kolling Institute, New South Wales’ oldest medical research institute.
Co-hosted by the Kolling Institute’s Academic Director Profess.....
Read more
Category: Cardiovascular and Renal Research, Musculoskeletal Research, Neuroscience and Pain Research, Research Excellence
Posted on: 24 June, 2025
The inaugural Eva Kolling Research Day was staged within Royal North Shore Hospital, providing the perfect chance to celebrate the vision and generosity of a true pioneer.
Established in 1920, the Kolling Institute is the oldest medical research institute in New South Wales. It has been at the forefront of cutting-edge research for more than a hundred years, with its founding director Dr W. Wilson .....
Read more
Category: Awards, Cardiovascular and Renal Research, Funding support, Musculoskeletal Research, Neuroscience and Pain Research, Research Excellence
Posted on: 23 June, 2025
Researchers from Royal North Shore Hospital and the Kolling Institute will lead Australia’s first study of whole-body screening for young people with neurofibromatosis type 1.
Led by Dr Sue-Faye Siow from the department of clinical genetics, the study was awarded a grant through the RNSH Campus Research Grants Scheme, and an additional $30,000 in support from the NORTH Foundation.
Neurofibromatosis.....
Read more
Category: New Treatment, Research Excellence
Posted on: 29 May, 2025
International Clinical Trials Day provided the chance to recognise the many people contributing to our life-changing clinical trials.
Two key events were staged to mark the day, including a presentation in the Kolling auditorium from leading clinical trial investigators, and a public display within Royal North Shore Hospital.
More than 300 trials are underway across Northern Sydney including .....
Read more
Category: New Treatment, Research Excellence
Posted on: 23 May, 2025
Check out our latest newsletter
Researchers target sleep for muscle pain relief
Landmark clinical trial to improve lung cancer treatment
Pioneering Muscle Map project receives funding support
Travel awards for emerging research leaders
And much more:
Click here:
Read more
Category: Cardiovascular and Renal Research, Musculoskeletal Research, Neuroscience and Pain Research, Newsletters, Research Excellence, World-leading technology
Posted on: 15 May, 2025
Leading Royal North Shore Hospital clinician researcher Professor Nick Pavlakis and Professor Ben Solomon have secured a $14.7 million MRFF grant for a clinical trial which will explore the use of a liquid biopsy to inform treatment for lung cancer.
The condition is the leading cause of cancer death in Australia and worldwide, claiming an estimated 9,000 lives in Australia each year.
The pioneering.....
Read more
Category: Funding support, Research Excellence
Posted on: 07 March, 2025
A two-decade long commitment to reducing blood cancers has delivered coveted national funding to Associate Professor Jenny Wang to progress her vital cancer research.
As the head of the Kolling Institute’s Cancer and Stem Cell Laboratory, Associate Professor Wang has secured a $2.95 million investigator grant from the National Health and Medical Research Council to advance her pioneering research i.....
Read more
Category: Funding support, Research Excellence
Posted on: 13 December, 2024
A special visit by two international cancer specialists could mark the start of a valuable collaborative partnership.
Professor Matthew Katz from the MD Anderson Cancer Centre in Houston Texas is recognised as a pioneer in the treatment of pancreatic cancer, while Professor Cynthia Sears from the Johns Hopkins University School of Medicine in Baltimore is a global leader in colorectal cancer resear.....
Read more
Category: Presentations, Research Excellence
Posted on: 11 December, 2024
An exciting partnership between AGRF Ltd (Australian Genome Research Facility) and the University of Sydney and the Kolling Institute will help strengthen genomic capabilities.
The partnership will see a specialised team and cutting-edge technology located within the institute to progress research in this increasingly crucial field.
As Australia’s largest provider of genomic services, AGRF supports.....
Read more
Category: New Treatment, Research Excellence
Posted on: 15 November, 2024
We would like to thank everyone involved in the 2024 Kolling Institute Symposium.
During the event, a diverse collection of researchers detailed the latest progress with their ground-breaking work into kidney and heart disease treatments, bone and muscle conditions, rare cancers, and neurological challenges. There was a focus too on the innovative work to develop a unique wellbeing index.
Researche.....
Read more
Category: Cardiovascular and Renal Research, Musculoskeletal Research, Neuroscience and Pain Research, Presentations, Research Excellence